期刊文献+

血液灌流联合复方α酮酸对维持性血液透析患者微炎症及营养状况的影响 被引量:19

Effects of combined use of hemoperfusion and α-keto acid on microinflammation and nutrition status in patients with maintenance hemodilysis
原文传递
导出
摘要 目的探讨血液灌流(HP)联合复方α酮酸(α-KA)对维持性血液透析(MHD)患者微炎症状态及营养状况的影响。方法 MHD患者90例随机均分为三组,分别接受单纯血液透析(HD)(A组)、HP联合HD(B组)或HP联合HD并加用α-KA口服(C组)治疗。治疗前及治疗6个月后,结合临床症状进行营养不良-炎症反应评分(MIS),测量体重指数(BMI),测定C反应蛋白(CRP)、血浆白蛋白(Alb)、总胆固醇(TC)、血清肌酐(SCr)、尿素氮(BUN)和血红蛋白(Hb),计算尿素清除率(Kt/V)。结果治疗6个月后,B和C组MIS评分分别为(5.28±1.49)分和(3.36±1.10)分,均明显低于A组的(10.90±3.15)分(P<0.01)。B、C组Alb和Hb也较A组有明显升高,CRP则明显下降(P<0.05)。结论 HP联合α-KA治疗可明显改善MHD患者的营养状况,减轻微炎症状态。 Objective To study the effects of combined use of hemoperfusion and a-keto acid (a-KA) on microinflammation and nutrition status in the patients undergoing maintenance hemodilysis (MHD). Methods Ninety MHD patients were equally randomized into three groups of A(hemodilysis alone) ,B(hemodilysis and hemoperfusion) and C(hemodilysis and hemoperfusion plus oral a-KA). Malnutrition inflammation score (MIS), body mass index (BMI), C-reactive protein (CRP), albumin ( Alb ), total cholesterol ( TC ), serum creatinine ( SCr ), blood urea nitrogen (BUN), hemoglobin (Hb) and Kt/V were determined before and at 6 months after treatment. Results After treated for six months,MIS scores in groups of B and C were (5.28q-1.49) points and (3. 36±1.10) points,which were remarkably lower than (10. 90±3.15) points in group A(P〈0. 01). At the same time, Alb and Hb were higher, but CRP was lower, in groups of B and C than those in group A(P〈0.05). Conclusion Hemoperfnsion and HP combined with a-KA can effectively ameliorate the malnutrition and mircroinfla in MHD patients.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第24期2967-2969,共3页 Jiangsu Medical Journal
关键词 维持性血液透析 复方Α酮酸 血液灌流 Maintenance hemodilysis a-Keto acid Hemoperfusion
  • 相关文献

参考文献9

  • 1Stenvinkel P, Heimburger O, Paultre F, et al. Strong associa- tion between malnutrition, inflammation, and atherosclerosisin chronic renal failure[J]. Kidney Int,1999,55(5):1899-1911.
  • 2Lindsay RM, Heidenheim AP, Spanner E, et al. Adequacy of hemodialysis and nutirtion-important determinants of morbidity and mortality[J]. Kidney Int Suppl, 1994,44 :85-91.
  • 3Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients[J]. Am J Kidney Dis, 2001,38(6) : 1251-1263.
  • 4Ho LC, Wang HH, Chiang CK, et al. Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients[J]. Blood Purif, 2010, 30 (1) : 16-24.
  • 5Wellen KE, Hotamisligil GS. Imflammation, stress, and diabetes[J]. J Clin Invest,2005,115(5) :1111-1119.
  • 6Stenvinkel P, Barany P, Heimbiirger O, et al. Mortality, malnutrition,and atherosclerosis in ESRD: what is the role of interleukin -6[J]? Kidney Int Suppl,2002,80:103-108.
  • 7Kaysen GA. C-reactive protein: a story half told[J]. Semin Dial, 2000,13(3) : 143-146.
  • 8谌卫,郭志勇,吴灏,孙莉静,蔡莉莉,徐海燕.复方α-酮酸配伍低蛋白饮食对长期腹膜透析患者微炎症的影响及其与营养状态关系的随机对照研究[J].中西医结合学报,2008,6(5):473-477. 被引量:22
  • 9Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approaeh[J]. J Am Soe Nephrol,2004,15(Suppl 1) :21-24.

二级参考文献10

  • 1Moshyedi AK, Josephs MD, Abdalla EK, et al. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha. Infect Immun. 1998; 66(4) : 1800-1802.
  • 2Teplan V, Schtick O, Knotek A, et al. Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study. Ann Transplant. 2001; 6(1): 47-53.
  • 3Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999.55(2): 648-658.
  • 4Stenvinkel P, Heimbtirger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55(5): 1899-1911,
  • 5Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis. 2003 ; 42 : 295-302.
  • 6Kaizu Y, Kimura M, Yoneyama T, et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998. 31(1): 93-100.
  • 7Bergstrom J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial. 2000; 13 (3) : 163-175.
  • 8McCusker FX, Teehan BP, Thorpe KE, et al. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl. 1996.56: S56-S61.
  • 9Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int Suppl. 2000; 58: 96-103.
  • 10Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis. 1997; 30(6): 923-927.

共引文献21

同被引文献188

引证文献19

二级引证文献194

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部